Tag «MM-36-Medimetriks-Pharmaceuticals»

Difamilast

It’s only fair to share… Difamilast PMDA Moizerto, JAPAN APPROVED 2021/9/27 ジファミラスト ディファミラスト; 地法米司特 N-({2-[4-(difluoromethoxy)-3-(propan-2-yloxy)phenyl]-1,3- oxazol-4-yl}methyl)-2-ethoxybenzamide OPA-15406 Formula C23H24F2N2O5 CAS 937782-05-3 Mol weight 446.4439 MM 36; MM-36-Medimetriks-Pharmaceuticals; Moizerto; OPA-15406 Efficacy Anti-inflammatory, Phosphodiesterase IV inhibitor Comment Treatment of atopic dermatitis OriginatorOtsuka Pharmaceutical Development & Commercialization DeveloperMedimetriks Pharmaceuticals; Otsuka Pharmaceutical Development & Commercialization ClassBenzamides; Nonsteroidal anti-inflammatories; Oxazoles; Skin disorder …